EFM
ABVX

E Fund Management’s Abivax ABVX Stock Holding History

E Fund Management’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.53M Buy
+13,732
New +$1.63M 0.05% 169

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

E Fund Management's ABVX Position: Q1 2026 in Review

E Fund Management opened a new position in Abivax (ABVX) in Q1 2026: 13,732 shares worth $1.53M. The stake represents 0.05% of the portfolio and ranks #169 among its holdings.

254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • E Fund Management held 13,732 shares of Abivax worth $1.53M as of Q1 2026.
  • Abivax was a new E Fund Management position in Q1 2026.
  • Abivax made up 0.05% of E Fund Management's portfolio in Q1 2026, its #169 holding.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on E Fund Management's 13F filing for Q1 2026, filed 13 Apr 2026.